The Current Ratio as of November 2025 (TTM) for Intellipharmaceutics International Inc. (IPCIF) is 0.04

According to Intellipharmaceutics International Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.04. This represents a change of -29.99% compared to the average of 0.06 of the last 4 quarters.

Intellipharmaceutics International Inc. (IPCIF) Historical Current Ratio (quarterly & annually)

How has IPCIF Current Ratio performed in the past?

The mean historical Current Ratio of Intellipharmaceutics International Inc. over the last ten years is 0.77. The current 0.04 Current Ratio has changed 432.92% with respect to the historical average. Over the past ten years (40 quarters), IPCIF's Current Ratio was at its highest in in the February 2014 quarter at 2.59. The Current Ratio was at its lowest in in the November 2022 quarter at 0.04.

Intellipharmaceutics International Inc. (IPCIF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Intellipharmaceutics International Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intellipharmaceutics International Inc. (IPCIF) Average Current Ratio

How has IPCIF Current Ratio performed in the past?

The current Current Ratio of Intellipharmaceutics International Inc. (IPCIF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Intellipharmaceutics International Inc. (IPCIF) Current Ratio vs. Peers

How is IPCIF’s Current Ratio compared to its peers?

Intellipharmaceutics International Inc.’s Current Ratio is less than Tryp Therapeutics Inc. (0.24), less than BerGenBio ASA (4.39), less than Acreage Holdings, Inc. (1.14), greater than China Infrastructure Construction Corp. (0.02), less than Acreage Holdings, Inc. (1.14), less than Pascal Biosciences Inc. (0.79), less than Indiva Limited (0.72), less than Dogecoin Cash, Inc. (1.01), less than Rhinomed Limited (0.27), less than Pixium Vision S.A. (1.19),

Build a custom stock screener for Intellipharmaceutics International Inc. (IPCIF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intellipharmaceutics International Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intellipharmaceutics International Inc. (IPCIF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intellipharmaceutics International Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.